돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2054702생성일: 2026년 10월 26일

Isradipine → 2-Acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester

https://huagongshe.com/reaction/2054702

반응식

참여 물질

역할이름HCID투입량
반응물IsradipineHCID 3784—
반응물Methyl acetoacetateHCID 7757—
반응물PiperidineHCID 8082—
반응물2,1,3-Benzoxadiazole-4-carbaldehydeHCID 10290873—
용매Acetic AcidHCID 176—
용매Diisopropyl EtherHCID 7914—
생성물2-Acetyl-3-benzofurazan-4-yl-acrylic acid methyl esterHCID 53433213—

반응 단계

To achieve the afore-mentioned objects, the present invention provides for a process for the manufacture of the Isradipine which, involves two steps. In the first step 2,1,3-benzoxadiazole-4-carboxaldehyde is reacted with methyl acetoacetate in the presence of acetic acid and piperidine in diisopropyl ether. The product 2-acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester is isolated and purified to get substantially high purity product with less than 0.3% 2,1,3-benzoxadiazole-4-carboxaldehyde content present in the purified product. In the second step the purified intermediate 2-acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester is reacted with isopropyl-β-aminocrotonate in ethanol at 25 to 35° C. The crude Isradipine is crystallised from ethanol to get pure Isradipine having substantially higher purity and containing lower amount of the symmetrical ester isomers (III) and (IV).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07329756B2
출처 데이터셋uspto-grants-2008_02
ORD IDord-391dc78fba9444bda56964b252ebf9ae
출처 메모uspto-grants-2008_02